Leukemia, and Its Treatment, May Pose Neurocognitive Risks

FRIDAY, April 6, 2018 -- Underlying leukemia, even before chemotherapy, may pose a neurocognitive risk to young patients, according to a study published online March 29 in JAMA Oncology. Yin Ting Cheung, Ph.D., from the St. Jude Children ' s Research...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news